Benchmarking Quality in the Healthcare Sector: Agility and Outsourcing

STUDY OVERVIEW

The quality function in the biopharmaceutical industry is undergoing change as leaders are being forced to maintain a cost efficient quality organization while also effectively managing risk. These twin challenges have quality leaders examining their group's agility capability and use of outsourcing.

Best Practices, LLC conducted this study to probe ways in which high-performing quality groups are becoming more agile and utilizing outsourcing. The study addresses the challenges companies face in becoming more agile and the approaches they use to enable them to respond quickly to issues. For outsourcing, the study looks at where organizations are using outsourcing across five functional areas as well as the ratio of outsourced manufacturing plants vs. company operated.

Quality leaders can use this study to assess their quality practices regarding agility and outsourcing.

KEY TOPICS

• Quality Agility Excellence
• Quality Outsourcing Excellence

SAMPPLE KEY METRICS

• Top three challenges for quality organization becoming more agile
• How do you assess your processes, strategy and employee attributes?
• Effectiveness of approaches for developing systems to respond to problems and opportunities
• Impact rating for factors affecting where quality centers are located
• Mix of company employees and outsourced FTEs across different roles
• Number of company run and contractor run manufacturing plants in seven regions

SAMPLE KEY FINDINGS

• Risk prioritization and simplification of design and systems are most effective tools to proactively address problems and seize opportunities.
• On average, 13% of quality FTEs are outsourced. As the level of outsourcing increases, quality spend as a percentage of revenue decreases.

METHODOLOGY

The research employed a data gathering approach that reaps quantitative & qualitative data from
a diverse group of 22 companies. This study includes segmented data for biopharma and medical device companies.

Industries Profiled:
Medical Device; Pharmaceutical; Diagnostic; Manufacturing; Consulting; Biotech; Biopharmaceutical; Health Care; Clinical Research; Laboratories


Companies Profiled:
Boston Scientific; idera pharmaceuticals; Astellas; seracare; GlaxoSmithKline ; GN Hearing; 3M Company; Neopharm; Amgen; NewLink Genetics; Abbvie; Takeda Pharmaceuticals; Daiichi Sankyo; DePuy Synthes; Baxter Healthcare; Novartis; Tesaro; Biogen; Sanofi; Abbott; Medtronic; Beckman Coulter

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.